We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BG icon
101
Bunge Global
BG
$21.1B
$1.6M 0.17%
22,975
-5,388
-19% -$386K
PNC icon
102
PNC Financial Services
PNC
$101B
$1.56M 0.16%
11,572
– –
EW icon
103
Edwards Lifesciences
EW
$51.7B
$1.54M 0.16%
31,800
– –
DUK icon
104
Duke Energy
DUK
$97.6B
$1.52M 0.16%
19,249
-2,016
-9% -$155K
OAK
105
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$1.51M 0.16%
37,200
– –
PX
106
DELISTED
Praxair Inc
PX
$1.51M 0.16%
9,559
+400
+4% +$61.8K
USB icon
107
US Bancorp
USB
$99.6B
$1.47M 0.15%
29,344
– –
GAM
108
General American Investors Company
GAM
$1.61B
$1.42M 0.15%
41,400
+3,462
+9% +$119K
CSX icon
109
CSX Corp
CSX
$93.7B
$1.38M 0.15%
64,914
-300
-0.5% -$6.18K
TD icon
110
Toronto Dominion Bank
TD
$200B
$1.34M 0.14%
23,082
– –
FTV icon
111
Fortive
FTV
$18.7B
$1.3M 0.14%
26,791
-1,190
-4% -$56.8K
EOG icon
112
EOG Resources
EOG
$71.2B
$1.23M 0.13%
9,890
-99
-1% -$11.5K
COF icon
113
Capital One
COF
$133B
$1.23M 0.13%
13,386
– –
BX icon
114
Blackstone
BX
$110B
$1.13M 0.12%
35,092
+1,619
+5% +$51.5K
FLS icon
115
Flowserve
FLS
$10.2B
$1.13M 0.12%
27,858
– –
TGT icon
116
Target
TGT
$67.4B
$1.11M 0.12%
14,625
+1,000
+7% +$73.6K
CL icon
117
Colgate-Palmolive
CL
$74.5B
$1.1M 0.12%
16,946
-2,549
-13% -$167K
NTRP
118
DELISTED
Neurotrope, Inc. Common
NTRP
$1.06M 0.11%
+109,375
New +$1.01M
CNI icon
119
Canadian National Railway
CNI
$76.9B
$1.05M 0.11%
12,842
– –
CSCO icon
120
Cisco
CSCO
$478B
$1.03M 0.11%
23,882
-1,475
-6% -$64.4K
SU icon
121
Suncor Energy
SU
$70.8B
$1M 0.11%
24,593
+350
+1% +$13.6K
SLRC icon
122
SLR Investment Corp
SLRC
$716M
$991K 0.1%
48,500
– –
NEM icon
123
Newmont
NEM
$118B
$982K 0.1%
26,050
-50
-0.2% -$1.97K
PM icon
124
Philip Morris
PM
$295B
$972K 0.1%
12,035
-25
-0.2% -$2.12K
MO icon
125
Altria Group
MO
$114B
$958K 0.1%
16,875
-2,300
-12% -$133K
3 4
5
6 7

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.